NCT04436679Completed
INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors
Source: ClinicalTrials.gov · Last updated 30 Mar 2025
Brief summary (registry, in English)
The study is particularly innovative as it will accurately analyze the microscopic characteristics of the stroma, tumor budding and mucin expression in adenocarcinomas of the pancreas, using a comparative approach of long-survivor/short-survival patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 342 (actual)
- First submitted
- 15 Jun 2020
- Start date
- 2 Feb 2021
- Primary completion date
- 22 Feb 2025
- Lead sponsor
- University Hospital, Lille
- Diseases
- Pancreatic cancer
- NCT number
- NCT04436679
What you commit to
- Study type: Observational
- Participants enrolled: 342
- From 2 Feb 2021 to the primary completion date, 22 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient died due to post-surgical complications (death within 30 days post-surgery).
- Surgical resection of macroscopic R2 type.
Other illness
- Absence of Primary Cancer Tissue Blocks (PCTBs)
- Pancreatic cancer not corresponding to a conventional excretopancreatic adenocarcinoma such as: carcinoma on intraductal papillary mucinous neoplasm, endocrine tumor/carcinoma, acinar cell carcinoma, ...).
Other
- Paraffin block fixed in Bouin or AFA
- Patient Refusal
Who the study is looking for
- Patients \> 18 years of age at diagnosis
- Primary pancreatic cancer patients operated on in one of the 4 centres between 2001 and 2016
- Histopathological diagnosis of excreto-pancreatic adenocarcinoma of the pancreas, ductal adenocarcinoma or classical adenocarcinoma
- Tissue blocks (FFPE) available (tumour/healthy tissue)
- Affiliated to a social security scheme
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hop Claude Huriez Chu Lille Coordinator of this site? Confirm its status | Lille | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.